# Samsung Next

> Samsung Next is Samsung Electronics’ corporate venture arm, investing in startups across AI, robotics, health technology, consumer services and frontier technology. It combines equity investment with help navigating Samsung’s businesses; its history also includes acquisitions and product development.

- **Founded:** 2012
- **Headquarters:** Mountain View, United States
- **Founders:** David Eun (Founder and former President)
- **Products:** Venture investment, Samsung ecosystem navigation, Samsung NEXT Fund, Acquisitions and product development
- **Notable:** Reports 350+ portfolio companies since 2012., Announced a $150 million venture fund in January 2017., Predecessor organization facilitated the LoopPay investment and spearheaded the Viv acquisition.

## Products & services

- **Venture investment** — Equity capital for technology startups; the current approach describes minority, non-lead participation across stages.
- **Samsung ecosystem navigation** — Support in identifying commercial relationships and relevant teams within Samsung.
- **Samsung NEXT Fund** — A $150 million fund announced for pre-seed through Series B software and services investments.
- **Acquisitions and product development** — Historical innovation activities include the predecessor organization’s work on LoopPay and Viv, and Whisk joining the Next product team.

## Achievements

- Reports 350+ portfolio companies since 2012.
- Announced a $150 million venture fund in January 2017.
- Predecessor organization facilitated the LoopPay investment and spearheaded the Viv acquisition.
- Whisk joined Samsung Next’s product team in 2019 and became Samsung Food in 2023.

## Latest updates

- **2026-10** — Daytona named Samsung Next as a strategic investor in its $60 million Series B, announced October 20; Next’s individual contribution was not disclosed.
- **2026-02** — Odyssey announced investment from NVentures and Samsung Next to support general-purpose world simulation research; the amount was not disclosed.
- **2026-02** — Samsung Next’s blog lists an investment thesis on Nucleus and clinical-grade genomics.

## Links

- Website: https://www.samsungnext.com/
- LinkedIn: https://www.linkedin.com/company/samsung-next
- Twitter/X: https://x.com/samsungnext
- Facebook: https://facebook.com/SamsungNEXT/

---

Profile page: https://yespress.io/samsung-next
Published by YesPress — https://yespress.io
Last updated: 2026-10-27